Printer Friendly

BIOMUNE SYSTEMS, INC. BOARD OF DIRECTORS APPROVES STOCK SPLIT, DIVIDENDS

 SALT LAKE CITY, Utah, March 11 /PRNewswire/ -- Biomune Systems Inc., a biogenetic company specializing in drugs that strengthen the immune system, announced today that its board of directors has taken action on two items that directly influence its shareholders. The first is the approval of 1-for-100 reverse split of Biomune's common stock effective March 22, 1993. The effect of the reverse split on holders of Biomune's common stock is to give each shareholder of record on March 22, 1993 one share of common stock for each 100 shares of common stock owned prior to the stock split.
 While the number of shares of Biomune's common stock owned by each shareholder will be reduced as a result of the stock split, each shareholder's percentage ownership of Biomune will not change. The stock split was approved by Biomune's board of directors in order to increase the market price of Biomune's common stock and place Biomune's stock price in the price range necessary to meet the stock price requirement for NASDAQ listing. Management also believes that the stock split will facilitate the raising of capital for Biomune.
 The second action taken by Biomune's board of directors is the approval of a "loyalty" share dividend to Biomune's stockholders of record on Dec. 31, 1993, consisting of one share of a newly formed, wholly owned environmental waste technology corporation for each share of Biomune common stock owned on Dec. 31, 1993.
 Any question concerning these actions taken by the board of directors of Biomune, please contact David Derrick, president, at 801-364-5850.
 -0- 3/11/93
 /CONTACT: David Derrick, president of Biomune Systems, Inc., 801-364-5850/


CO: Biomune Systems Inc. ST: Utah IN: MTC SU: DIV

TS -- NY042 -- 5085 03/11/93 12:03 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 11, 1993
Words:288
Previous Article:AMERICANS' HEALTH HABITS TURN FOR WORSE: WEIGHT UP, NUTRITION AND EXERCISE DOWN, BAXTER SURVEY SAYS
Next Article:THE LIPOSOME COMPANY DECLARES FIRST
Topics:


Related Articles
SCIENTIFIC-ATLANTA ANNOUNCES 3-FOR-2 STOCK SPLIT; RAISES CASH DIVIDEND 13 PERCENT; INSTITUTES DIVIDEND REINVESTMENT PLAN
BIOMUNE SYSTEMS, INC. ANNOUNCES PRECLINICAL DRUG FOR PREVENTING AND TREATING CRYPTOSPORIDIOSIS IN ANIMALS
Biomune Systems, Inc. Announces Acquisition
Biomune Systems, Inc. Announces First Time Operational Profits.
BEA Stockholders Approve Two-for-One Stock Split.
Protein Design Labs Announces Two-for-One Stock Split.
Biomune Systems, Inc. and Donlar Corporation Announce Business Combination.
Biomune Systems, Inc. Announces Donlar Corporation Will Transfer Certain Assets in Exchange for Biomune Common Stock.
Biomune Systems, Inc. Announces the Completion of Transfer of Certain Assets by Donlar Corporation in Exchange for Biomune Common Stock.
Biomune Announces 8-K Filing.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters